tallózása szerző szerint "Bitter, István"

1-20 / 66

Következő oldal

12-week double-blind randomized multicenter study of efficacy and safety of agomelatine (25-50 mg/day) versus escitalopram (10-20 mg/day) in out-patients with severe generalized anxiety disorder

Stein DJ; Khoo JP; Ahokas A; Jarema M; Van Ameringen M; Vavrusova L; Hoschl C; Bauer M; Bitter, István; Mosolov SN; Olivier V; Matharan S; Picarel-Blanchot F; de Bodinat C (2018)

Treatment of severely symptomatic patients with generalized anxiety disorder (GAD) raises particular concerns for clinicians. This 12-week double-blind study evaluated the efficacy of agomelatine (25-50 mg/day) in the ...
A blind spot on the global mental health map: a scoping review of 25 years' development of mental health care for people with severe mental illnesses in central and eastern Europe.

Winkler P; Krupchanka D; Roberts T; Kondratova L; Machu V; Hoschl C; Sartorius N; Van Voren R; Aizberg O; Bitter, István; Cerga-Pashoja A; Deljkovic A; Fanaj N; Germanavicius A; Hinkov H; Hovsepyan A; Ismayilov FN; Ivezic SS; Jarema M; Jordanova V; Kukic S; Makhashvili N; Sarotar BN; Plevachuk O; Smirnova D; Voinescu BI; Vrublevska J; Thornicroft G (2017)

Just over 25 years have passed since the major sociopolitical changes in central and eastern Europe; our aim was to map and analyse the development of mental health-care practice for people with severe mental illnesses ...
A büntetőeljárásban alkalmazható agyi ujjnyomat (brain fingerprinting) vallomásellenőrzési módszer, és annak neurobiológiai alapja, a P300 agyhullám

Czobor, Pál; Kakuszi, Brigitta; Fantoly, Zsanett; Bitter, István; Budaházi, Árpád (2018)
ADHD: a hidden comorbidity in adult psychiatric patients

Bitter, István; Mohr Pavel; Balogh, Lívia; Látalová Klára; Kakuszi, Brigitta; Stopková Pavla; Zmeškalová-Jelenová Daniela; Pulay, Attila József; Czobor, Pál (2019)

Adult attention-deficit/hyperactivity disorder (aADHD) has recently been better recognized and treated in many European countries. In spite of this development, aADHD still features as a "hidden" comorbidity, often not ...
Adherencia és a tartós hatású (depot) antipszichotikumok alkalmazása szkizofréniában

Bitter, István (2015)
Agykutatás és pszichiátria

Bitter, István; Czobor, Pál (2015)
A kognitív rugalmasság neurobiológiai korrelátumainak vizsgálata ADHD-ban - Irodalmi áttekintés

Bálint, Sára; Bitter, István; Czobor, Pál (2015)

INTRODUCTION: Attention deficit hyperactivity disorder (ADHD) is one of the most commonly diagnosed childhood psychiatric disorders, which persists to adulthood in 30-50% of the cases. Previous studies have shown that ...
A large European, multicenter, multinational validation study of the Brief Negative Symptom Scale

Mucci, Armida; Vignapiano, Annarita; Bitter, István; Austin, Stephen F; Delouche, Camille; Dollfus, Sonia; Erfurth, Andreas; Fleischhacker, W Wolfgang; Giordano, Giulia M; Gladyshev, Igor; Glenthøj, Birte; Gütter, Karoline; Hofer, Alex; Hubeňák, Jan; Kaiser, Stefan; Libiger, Jan; Melle, Ingrid; Nielsen, Mette Ø; Papsuev, Oleg; Rybakowski, Janusz K; Sachs, Gabriele; Üçok, Alp; Wojciak, Pawel; Galderisi, Silvana (2019)

Negative symptoms represent an unmet need of treatment in schizophrenia. Although a consensus exists on negative symptom construct, and second generation assessment instruments reflecting the consensus are available, studies ...
Alterations in resting-state gamma activity in patients with schizophrenia: a high-density EEG study

Baradits, Máté; Kakuszi, Brigitta; Bálint, Sára; Fullajtár, Máté; Mod, L; Bitter, István; Czobor, Pál (2019)

Alterations of EEG gamma activity in schizophrenia have been reported during sensory and cognitive tasks, but it remains unclear whether changes are present in resting state. Our aim was to examine whether changes occur ...
Altered response-preparation in patients with adult ADHD: A high-density ERP study.

Kakuszi B; Tombor, László; Papp, Szilvia; Bitter, István; Czobor, Pál (2016)

Aberrations in early-developing bottom-up processes, such as stimulus-driven response preparation, are thought to play a critical role in the onset of ADHD, and in its persistence over time. Electrophysiology offers a ...
A multi-centre, randomised, double-blind, placebo-controlled clinical trial of methylphenidate in the initial treatment of acute mania (MEMAP study)

Hegerl U; Mergl R; Sander C; Dietzel J; Bitter, István; Demyttenaere K; Gusmao R; Arrillaga AG; Zorrilla I; Alocen AG; Sola VP; Vieta E; Juckel G; Zimmermann US; Bauer M; Sienaert P; Quintao S; Edel MA; Bolyos C; Ayuso-Mateos JL; Lopez-Garcia P; Kluge M (2018)

Based on many clinical and preclinical findings the 'vigilance regulation model of mania' postulates that an unstable regulation of wakefulness is a pathogenetic factor in both mania and Attention Deficit Hyperactivity ...
Antipszichotikumok kombinációjának használata szkizofrénia kezelésében. Irodalmi áttekintés

Gazdag Gábor, László; Tolna, Judit; Bitter, István (2012)

Main indication for antipsychotic medication is the treatment of schizophrenia and other psychotic disorders. Influential protocols in the treatment of schizophrenia recommend the use of antipsychotics in monotherapy. In ...
A proposal for a psychopharmacology-pharmacotherapy catalogue of learning objectives and a curriculum in Europe

Baumann P; Spies M; Moller HJ; Kasper S; Bitter, István; Laux G (2017)

OBJECTIVES: Post-graduate training for specialisation in psychiatry and psychotherapy is part of a 4 to 6 year program. This paper aims to inform on the general situation of teaching and training of psychopharmacology-p ...
A pszichiátria elmúlt 20 évének főbb eseményei és eredményei:1993-2013

Bitter, István (2013)
A pszichiátriai betegségekre jelentős korai halálozási arányszámok jellemzők: szomatikus komorbiditás és mortalitás autizmusspektrum-zavarban és szkizofréniában

Bitter, István; Czobor, Pál; Kakuszi, Brigitta; Réthelyi, János (2023)

A pszichiátriai betegségekkel összefüggő jelentős halálozásért nagy részben a szomatikus betegségekkel való komorbiditás esetén bekövetkező korai halálozás, továbbá részben az öngyilkosság és a balesetek a felelősek. ...
A systematic review of health economic models and utility estimation methods in schizophrenia.

Németh, Bertalan; Fasseeh A; Molnar A; Bitter, István; Horvath M; Koczian K; Gotze A; Nagy, Balázs (2018)

INTRODUCTION: There is a growing need for economic evaluations describing the disease course, as well as the costs and clinical outcomes related to the treatment of schizophrenia. Areas covered: A systematic review on ...
Atípusos antipszichotikumok és antidepresszív szerek terápiás gyógyszerszint-monitorozása: egy év tapasztalatai a Semmelweis Egyetemen

Karvaly, Gellért Balázs; Bitter, István (2020)

INTRODUCTION: Pharmacotherapy supported by therapeutic drug monitoring (TDM) has a tradition in psy - chiatry. Novel diagnostic infrastructure based on mass spectrometry has been developed at Semmelweis University, allowing ...
Attention deficit hyperactivity disorder: Last in, first out - delayed brain maturation with an accelerated decline?

Kakuszi, Brigitta; Szuromi, Bálint; Bitter, István; Czobor, Pál (2020)
Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial

Nemeth G; Laszlovszky I; Czobor, Pál; Szalai E; Szatmari B; Harsanyi J; Barabassy A; Debelle M; Durgam S; Bitter, István; Marder S; Fleischhacker WW (2017)

BACKGROUND: Although predominant negative symptoms of schizophrenia can be severe enough to cause persistent impairment, effective treatment options are lacking. We aimed to assess the new generation antipsychotic cariprazine ...
Common variant at 16p11.2 conferring risk of psychosis

Steinberg S; de Jong S; Mattheisen M; Costas J; Demontis D; Jamain S; Pietilainen OP; Lin K; Papiol S; Huttenlocher J; Sigurdsson E; Vassos E; Giegling I; Breuer R; Fraser G; Walker N; Melle I; Djurovic S; Agartz I; Tuulio-Henriksson A; Suvisaari J; Lonnqvist J; Paunio T; Olsen L; Hansen T; Ingason A; Pirinen M; Strengman E; Hougaard DM; Orntoft T; Didriksen M; Hollegaard MV; Nordentoft M; Abramova L; Kaleda V; Arrojo M; Sanjuan J; Arango C; Etain B; Bellivier F; Meary A; Schurhoff F; Szoke A; Ribolsi M; Magni V; Siracusano A; Sperling S; Rossner M; Christiansen C; Kiemeney LA; Franke B; van den Berg LH; Veldink J; Curran S; Bolton P; Poot M; Staal W; Rehnstrom K; Kilpinen H; Freitag CM; Meyer J; Magnusson P; Saemundsen E; Martsenkovsky I; Bikshaieva I; Martsenkovska I; Vashchenko O; Raleva M; Paketchieva K; Stefanovski B; Durmishi N; Pejovic Milovancevic M; Lecic Tosevski D; Silagadze T; Naneishvili N; Mikeladze N; Surguladze S; Vincent JB; Farmer A; Mitchell PB; Wright A; Schofield PR; Fullerton JM; Montgomery GW; Martin NG; Rubino IA; van Winkel R; Kenis G; De Hert M; Réthelyi, János; Bitter, István; Terenius L; Jonsson EG; Bakker S; van Os J; Jablensky A; Leboyer M; Bramon E; Powell J; Murray R; Corvin A; Gill M; Morris D; O'Neill FA; Kendler K; Riley B; Craddock N; Owen MJ; O'Donovan MC; Thorsteinsdottir U; Kong A; Ehrenreich H; Carracedo A; Golimbet V; Andreassen OA; Borglum AD; Mors O; Mortensen PB; Werge T; Ophoff RA; Nothen MM; Rietschel M; Cichon S; Ruggeri M; Tosato S; Palotie A; St Clair D; Rujescu D; Collier DA; Stefansson H; Stefansson K (2014)

Epidemiological and genetic data support the notion that schizophrenia and bipolar disorder share genetic risk factors. In our previous genome-wide association study, meta-analysis and follow-up (totaling as many as 18 206 ...

1-20 / 66

Következő oldal

Keresés

Összetett keresés

Tallózás

Teljes repozitórumban

Hozzáférésem

Bejelentkezés

tallózása szerző szerint "Bitter, István"

DSpace/Manakin Repository

tallózása szerző szerint "Bitter, István"

Keresés

Tallózás

Teljes repozitórumban

Hozzáférésem